Laborie Medical Technologies Corp., a global leader in medical technology, has announced the appointment of Chris Smith as Chief Executive Officer, effective September 22, 2025. Smith succeeds Michael Frazzette, who retired after leading the company through significant growth and innovation.

With more than 30 years of executive leadership experience, Smith has previously served as CEO of NeoGenomics Laboratories, Ortho Clinical Diagnostics, and Cochlear Limited, driving transformative growth in each role. He has also held multiple board positions in both private and public companies, further strengthening his expertise in the healthcare sector.

Having served on Laborie’s Board of Directors since 2023, Smith is well-versed in the company’s mission and operations, ensuring a smooth leadership transition. He emphasized his commitment to advancing Laborie’s innovation across its core platforms in urology, gastroenterology, and obstetrics.

CXO TechBOT extends its best wishes to Chris Smith as he embarks on this new leadership journey at Laborie.